Sorted By:

Relevance


PhRMA Clinical Trial Principles Strengthen Authorship Standards

PhRMA  |  Press Release

Washington, D.C. (September 18, 2009) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement today regarding efforts to enhance transparency in...
https://www.phrma.org/press-release/phrma-clinical-trial-principles-strengthen-authorship-standards

PhRMA Statement Regarding FDA Oversight of Promotion Online

PhRMA  |  Press Release

Washington, D.C. (March 31, 2011) — Pharmaceutical Research and Manufacturers of America (PhRMA) Assistant General Counsel Jeffrey K. Francer issued the following statement today on the FDA’s anticipated social media guidance: "PhRMA has engaged the Food and Drug Administr...
https://www.phrma.org/press-release/phrma-statement-regarding-fda-oversight-of-promotion-online

PhRMA Statement on Biosimilar User Fees

PhRMA  |  Press Release

Washington, D.C. (December 6, 2011) —Pharmaceutical Research and Manufacturers of America (PhRMA) Vice President Sascha Haverfield-Gross today issued the following statement about user fees for biosimilars:   “PhRMA is pleased that the Food and Drug Administration (...
https://www.phrma.org/press-release/phrma-statement-on-biosimilar-user-fees

PhRMA Statement on Medicare Part D

PhRMA  |  Press Release

Washington, D.C. (July 15, 2011) — Pharmaceutical Research and Manufacturers of America (PhRMA) Vice President Karl Uhlendorf issued the following statement:   “It’s extremely unfortunate that President Obama continues to push for a policy that could destabilize the...
https://www.phrma.org/press-release/phrma-statement-on-medicare-part-d

PhRMA Applauds Passage of Russia PNTR

PhRMA  |  Press Release

Washington, D.C. (December 6, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani issued the following statement today: “We applaud Congress for approving Permanent Normal Trade Relations (PNTR) for Russia.  Improving trad...
https://www.phrma.org/press-release/phrma-applauds-passage-of-russia-pntr

David Brennan Elected PhRMA Board Chairman

PhRMA  |  Press Release

Washington, D.C. (April 3, 2009) — David Brennan, Chief Executive Officer, AstraZeneca, was elected board chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) today at the trade association’s annual meeting. Also elected were Pfizer Chairman and Chief Exec...
https://www.phrma.org/press-release/david-brennan-elected-phrma-board-chairman

Alabama Clinical Trials Benefit Patients and the Economy

PhRMA  |  Press Release

BIRMINGHAM, AL (December 4, 2013) – Working with Alabama research institutions, including several facilities in Birmingham, the nation’s biopharmaceutical research companies have conducted 3,431 clinical trials of new medicines in the state over the last 14 years, according to a ...
https://www.phrma.org/press-release/alabama-clinical-trials-benefit-patients-and-the-economy

PhRMA Statement on FDA Benefit Risk Assessment Plan

PhRMA  |  Press Release

WASHINGTON, D.C. (May 9, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) Vice President of Scientific and Regulatory Affairs Sascha Haverfield, Ph.D., issued the following statement today on the Food and Drug Administration’s (FDA) Draft PDUFA V Implement...
https://www.phrma.org/press-release/phrma-statement-on-fda-benefit-risk-assessment-plan

PhRMA Statement on Prescription Medicine Cost Growth

PhRMA  |  Press Release

Washington, D.C. (November 16, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement today:  “Mark Twain once mused: there are lies, damned lies and statistics. Unfortunately, ...
https://www.phrma.org/press-release/phrma-statement-on-prescription-medicine-cost-growth

PhRMA Statement on Commitment to R&D

PhRMA  |  Press Release

“The commitment to R&D by America’s pharmaceutical companies was recently underscored by a recent study released by Archstone Consulting and co-authored by University of Pennsylvania Wharton School economist Dr.
https://www.phrma.org/press-release/phrma-statement-on-commitment-to-randd

PhRMA Statement on the Senate Finance Committee Proposal

PhRMA  |  Press Release

(September 16, 2009) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson released the following statement about the Senate Finance Committee health care reform proposal: “We are currently reviewing the Senate Finance Committee health care reform proposal but we continue to believe that all Americans should have access to high-quality, affordable healthcare coverage and services.
https://www.phrma.org/press-release/phrma-statement-on-the-senate-finance-committee-proposal

PhRMA Statement on Health Care Reform

PhRMA  |  Press Release

(February 22, 2010) – The Pharmaceutical Research and Manufacturers of America (PhRMA) today released the following statement: “We remain committed to health care reform done in a fair and smart way.
https://www.phrma.org/press-release/phrma-statement-on-health-care-reform1

PhRMA Statement on Sequestration of PDUFA User Fees

PhRMA  |  Press Release

“PhRMA continues to work with lawmakers of both parties through the ongoing appropriations process towards the release of sequestered FY2013 prescription drug user fees and to prevent the sequestration of these fees in the future.”
https://www.phrma.org/press-release/phrma-statement-on-sequestration-of-pdufa-user-fees

PhRMA Statement on the ITC Report on India

PhRMA  |  Press Release

(December 22, 2014) — Pharmaceutical Research and Manufacturers of America (PhRMA) Deputy President, Mark Grayson issued the following statement: "PhRMA welcomes today’s release of the U.S.
https://www.phrma.org/press-release/phrma-statement-on-the-itc-report-on-india

PhRMA Statement on State of the Union

PhRMA  |  Press Release

Castellani released the following statement in response to the President's State of the Union address: “President Obama’s address comes at a time when the country’s biopharmaceutical research sector is bringing new treatment options to patients, supporting high-value American jobs and helping strengthen local and national economies.
https://www.phrma.org/press-release/phrma-statement-on-state-of-the-union

PhRMA Statement on House Health Care Reform Bill

PhRMA  |  Press Release

(October 29, 2009) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson released the following statement regarding the House health care reform bill: “Our top priority is to help ensure that a comprehensive health care reform bill gets to the President's desk this year so that millions of uninsured Americans have access to high-quality, affordable health care coverage and.facebook.com/sharer.php?
https://www.phrma.org/press-release/phrma-statement-on-house-health-care-reform-bill

New Report Shows Colorado Clinical Trials Benefit State’s Health and Economy

PhRMA  |  Press Release

Find PhRMA Online: Website – http://www.phrma.org facebook – www.facebook.com/PhRMA Blog – www.phrma.org/catalyst Twitter – www.Twitter.com/PhRMA and www.Twitter.com/PhRMApress YouTube – www.youtube.com/PhRMApress For information on how innovative medicines save lives, visit: http://www.innovation.org For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org For information on ensuring the flow of medicines during public health emergencies, visit http://www.rxresponse.org
https://www.phrma.org/press-release/new-report-shows-colorado-clinical-trials-benefit-state-s-health-and-economy

PhRMA Statement on President’s 2014 Budget

PhRMA  |  Press Release

 WASHINGTON, D.C. (April 10, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today: “President Obama has pressed for innovation and biomedical research, job creation, and controlling ...
https://www.phrma.org/press-release/phrma-statement-on-president-s-2014-budget

PhRMA Statement on Codes of Conduct

PhRMA  |  Press Release

Washington, D.C. (February 19, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement today regarding the Biotechnology Industry Organization’s position on codes of conduct for interactions with healthcar...
https://www.phrma.org/press-release/phrma-statement-on-codes-of-conduct

PhRMA Pleased with Progress on Brazil Cotton Case

PhRMA  |  Press Release

Washington, D.C. (April 6, 2010) — Pharmaceutical Research and Manufacturers of America (PhRMA) President, International, Christopher A. Singer issued the following statement today regarding the announced path toward a negotiated settlement with Brazil in the WTO Brazil-Cotton di...
https://www.phrma.org/press-release/phrma-pleased-with-progress-on-brazil-cotton-case

PhRMA Statement on Expanding Healthcare Coverage

PhRMA  |  Press Release

Washington, D.C. (May 5, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement today regarding expansion of healthcare coverage: “Our message during the healthcare reform discussions has been s...
https://www.phrma.org/press-release/phrma-statement-on-expanding-healthcare-coverage

PhRMA Statement on the Comparative Effectiveness Council

PhRMA  |  Press Release

Washington, D.C. (March 19, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement today regarding the Federal Coordinating Council on Comparative Effectiveness Research: “The economic stimulus ...
https://www.phrma.org/press-release/phrma-statement-on-the-comparative-effectiveness-council

PhRMA Statement on Flawed British Medical Journal Analysis

PhRMA  |  Press Release

Washington, D.C. (August 9, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today on the recent analysis in the British Medical Journal: “A new analysis in the British Me...
https://www.phrma.org/press-release/phrma-statement-on-flawed-british-medical-journal-analysis

PhRMA to Bestow New Research and Hope Award

PhRMA  |  Press Release

Washington, D.C. (August 27, 2012)— For the first time in its history, the Pharmaceutical Research and Manufacturers of America (PhRMA) will bestow a Research and Hope Award to individuals from academia, the patient and caregiving community as well as the biopharmaceutical sector...
https://www.phrma.org/press-release/phrma-to-bestow-new-research-and-hope-award

PhRMA Statement Supporting U.S. Economic Recovery Advisers

PhRMA  |  Press Release

Washington, D.C. (Jan. 21, 2011) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani issued the following statement today regarding the President’s new economic recovery advisory board: “PhRMA commends President Obama for establ...
https://www.phrma.org/press-release/phrma-statement-supporting-u-s-economic-recovery-advisers

You have reviewed the first 175 results out of 877. Each page contains 25 results. You're on page 7.

prev 7 8 9 10 11 12 next